Author

J. D. French

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Organism:human· 4 Research Focus:differential expression· 3 Approach:experimental assay· 3 Research Focus:gene regulatory network inference· 3 Approach:statistical model· 3 Approach:deep learning· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

W. Shi· 3 shared F. Casciello· 2 shared G. Chenevix-Trench· 2 shared H. Sivakumaran· 2 shared J. Beesley· 2 shared J. Rosenbluh· 2 shared M. Bitar· 2 shared S. Edwards· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

W. Shi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

CRISPR-Cas13d screens identify KILR a breast cancer risk-associated lncRNA that regulates DNA replication and repair.

L. Wang, M. Bitar, X. Lu, S. Jacquelin, S. Nair, H. Sivakumaran, K. M. Hillman, S. Kaufmann, R. Ziegman, F. Casciello, H. Gowda, J. Rosenbluh, S. L. Edwards, J. D. French

The paper identifies KILR, a breast cancer risk-associated lncRNA, and shows it regulates DNA replication and repair by sequestering RPA1.

bioRxiv · Nov 16, 2023 · PreprintCancer Biology

Redefining normal breast cell populations using long noncoding RNAs

M. Bitar, I. S. Rivera, I. Pimentel de Almeida, W. Shi, K. Ferguson, J. Beesley, S. Lakhani, S. Edwards, J. D. French

This study identifies and characterizes long noncoding RNAs in normal breast tissue, showing their utility in distinguishing cell subpopulations and improving cancer subtype classification.

bioRxiv · Sep 6, 2022Cell Biology

CRISPR screens identify gene targets and drug repositioning opportunities at breast cancer risk loci

N. K. Tuano, J. Beesley, M. Manning, W. Shi, L. Malver-Ortega, J. Paynter, D. Black, A. Civitarese, K. McCue, A. Hatzipantelis, K. Hillman, S. Kaufmann, H. Sivakumaran, J. M. Polo, R. Reddel, , J. Rosenbluh

bioRxiv · Sep 7, 2021 · PreprintCancer Biology

A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer

M. S. Miranda, J. M. Saunus, S. Akgül, M. Moradi Marjaneh, J. R. Kutasovic, W. Shi, O. Chatterjee, F. Casciello, E. Rozali, H. Y. Handoko, A. P. Wiegmans, T. Liu, J. S. Lee, B. W. Day, S. Edwards, , F. Al-Ejeh

This paper identifies a short ERK5 isoform that promotes extranuclear localization of active ERK5, driving EMT and poor survival in breast cancer.

bioRxiv · Mar 23, 2021Cancer Biology